Clincosm LogoSign in Get a demo

squamous cell carcinoma of head and neck

Showing 26 - 50 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma, Metastatic Breast Cancer, Advanced Renal Cell Carcinoma Trial in Worldwide (single arm)

Withdrawn
  • Metastatic Melanoma
  • +5 more
  • single arm
  • (no location specified)
Dec 20, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • sEphB4-HSA with chemotherapy
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 9, 2022

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Quantifying Systemic Immunosuppression to Personalize Cancer

Recruiting
  • Melanoma
  • +6 more
  • MDSC quantification
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +10 more
  • Singapore, Singapore
    Novartis Investigative Site
Nov 16, 2022

Melanoma, Squamous Cell Carcinoma of Head and Neck Trial (IO102-IO103, Pembrolizumab)

Not yet recruiting
  • Melanoma
  • Squamous Cell Carcinoma of Head and Neck
  • (no location specified)
Nov 7, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

Active, not recruiting
  • Hepatocellular Carcinoma
  • +11 more
  • Part 1 TPST-1120
  • +3 more
  • San Francisco, California
  • +10 more
Nov 1, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Pembrolizumab (Keytruda®), SAR444245 (Thor-707), Cetuximab

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab (Keytruda®)
  • +2 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 25, 2022

Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck Trial in Moscow (Intratumoral administration)

Recruiting
  • Sarcoma
  • +7 more
  • Intratumoral administration
  • Moscow, Russian Federation
  • +3 more
Oct 11, 2022

Obstructive Sleep Apnea, Squamous Cell Carcinoma of Head and Neck Trial in Aurora (Obstructive sleep apnea testing)

Withdrawn
  • Obstructive Sleep Apnea
  • Squamous Cell Carcinoma of Head and Neck
  • Obstructive sleep apnea testing
  • Aurora, Colorado
    University of Colorado Hospital
Oct 11, 2022

Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +7 more
  • Brussels, Brussel, Belgium
    Uz Brussel
Sep 2, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Lenvatinib, Pembrolizumab, Docetaxel)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Duarte, California
  • +87 more
Aug 18, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 9, 2022

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Optimisation of dental implant sites protection from irradiation
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Aug 2, 2022

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Squamous Cell Carcinoma of Head and Neck Trial in United States (CMP-001, Pembrolizumab)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Little Rock, Arkansas
  • +18 more
Aug 1, 2022

Squamous Cell Carcinoma of Head and Neck Trial in France (Pembrolizumab, Loco-regional radiotherapy, Chemotherapy)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Avignon, France
  • +20 more
Jul 28, 2022

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck Trial

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Ozuriftamab Vedotin
  • PD-1 inhibitor
  • (no location specified)
Jul 28, 2022

Decisional Conflicts, Health-related QoL and Satisfaction With

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +9 more
  • Regular care with additionally administration of questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Jul 28, 2022